The Association Between Diabetic Retinopathy and the Prevalence of Age-Related Macular Degeneration-The Kailuan Eye Study. 2022

Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology and Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China.

This study aimed to investigate the prevalence of age-related macular degeneration (AMD) in patients with diabetes mellitus (DM) and diabetic retinopathy (DR) and analyze whether DR is a risk factor for AMD. This population-based epidemiological study included 14,440 people from the Kailuan Eye Study in 2016, of whom 1,618 were patients with type 2 DM aged over 50 years, and 409 had DM with DR. We analyzed whether there were differences in the prevalence of AMD between DM with DR and DM without DR, and conducted a hierarchical statistical analysis according to different stages of DR. Using variable regression analysis, we explored whether DR constituted a risk factor for AMD. In the DM population, the prevalence of wet AMD in patients with DM with and without DR was 0. 3 and 0.2%, respectively, with no significant difference (P = 0.607). Meanwhile, the prevalence of dry AMD in patients with DM with and without DR was 20.8 and 16.0%, respectively, with a significant difference. In the subgroup analysis of dry AMD, the prevalence of early, middle, and late dry AMD in DM with DR was 14.4, 5.9, and 0.5%, respectively. In DM without DR, the prevalence of early, middle, and late dry AMD was 10.5, 4.8, and 0.7%, respectively (P = 0.031). In the subgroup analysis of DR staging, statistical analysis could not be performed because of the limited number of patients with PDR. In the variable regression analysis of risk factors for dry AMD, after adjusting for age, sex, body mass index, hypertension, and dyslipidemia, DR constituted the risk factor for dry AMD. In conclusion, DM did not constitute a risk factor for AMD, and the prevalence of wet AMD and dry AMD in patients with DM and DR was higher than that in patients with DM without DR (among which dry AMD was statistically significant). Multivariate regression analysis confirmed that DR is an independent risk factor for dry AMD. Reasonable control of DM and slowing down the occurrence and development of DR may effectively reduce the prevalence of AMD in patients with DM.

UI MeSH Term Description Entries
D008268 Macular Degeneration Degenerative changes in the RETINA usually of older adults which results in a loss of vision in the center of the visual field (the MACULA LUTEA) because of damage to the retina. It occurs in dry and wet forms. Maculopathy,Maculopathy, Age-Related,Age-Related Macular Degeneration,Age-Related Maculopathies,Age-Related Maculopathy,Macular Degeneration, Age-Related,Macular Dystrophy,Maculopathies, Age-Related,Age Related Macular Degeneration,Age Related Maculopathies,Age Related Maculopathy,Age-Related Macular Degenerations,Degeneration, Macular,Dystrophy, Macular,Macular Degeneration, Age Related,Macular Degenerations,Macular Dystrophies,Maculopathies,Maculopathy, Age Related
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D003930 Diabetic Retinopathy Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION. Diabetic Retinopathies,Retinopathies, Diabetic,Retinopathy, Diabetic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
August 2022, FP essentials,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
April 2022, Journal of personalized medicine,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
July 2012, American journal of preventive medicine,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
November 1990, Archives of ophthalmology (Chicago, Ill. : 1960),
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
October 2016, Archives of medical science : AMS,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
December 2006, American journal of ophthalmology,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
January 2002, Managed care (Langhorne, Pa.),
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
August 2019, Investigative ophthalmology & visual science,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
March 2024, Biomedicines,
Zhang Yongpeng, and Wang Yaxing, and Zhou Jinqiong, and Wang Qian, and Yan Yanni, and Yang Xuan, and Yang Jingyan, and Zhou Wenjia, and Wang Ping, and Shen Chang, and Yang Ming, and Luan Yanan, and Wang Jinyuan, and Wu Shouling, and Chen Shuohua, and Wang Haiwei, and Fang Lijian, and Wan Qianqian, and Zhu Jingyuan, and Nie Zihan, and Chen Yuning, and Xie Ying, and Jost B Jonas, and Wei Wenbin
May 2013, Retina (Philadelphia, Pa.),
Copied contents to your clipboard!